October 04, 2026
Quick answer: Yes. Corticosteroid creams used on the face, including over-the-counter hydrocortisone, are the trigger most consistently linked to perioral dermatitis: a rash of small red bumps around the mouth and nose. The cream calms the redness at first, the rash comes back harder when it is stopped, and the urge to reapply keeps the cycle going. Stopping safely is a conversation to have with a physician, because a rebound flare is expected.
Most people who end up with this rash did not think of their cream as a risk. Hydrocortisone is sold without a prescription, it was often recommended for something small (a patch of eczema, a bite, a dry spot, irritation from a new product), and it worked. When bumps appeared around the mouth a few weeks later, the natural move was to put a little more on, and it worked again for a few days. That sequence is exactly what makes the connection hard to see: the cream is both the thing that relieves the rash and the thing that sustains it.
A second assumption is that only "strong" steroids matter. Potency does matter, but it is not the whole story. In ten children with steroid-induced periorificial dermatitis, every one had used a topical corticosteroid on the face beforehand, ranging from low to high potency (Jansen 2010).
A corticosteroid suppresses inflammation and constricts small blood vessels, which is why redness fades within hours. Beneath that, it also slows the skin's barrier repair. In healthy adults, just three days of a potent steroid (clobetasol) delayed barrier recovery and weakened the cohesion of the stratum corneum. In mouse and cultured-cell experiments in the same study, the cause was a broad shutdown of epidermal lipid synthesis: fewer lamellar bodies, less of the ceramide, cholesterol and fatty acid layers that hold water in, and fewer corneodesmosomes holding the cells together (Kao 2003).
So the face ends up with less barrier than it started with, while the steroid hides the inflammation that a weak barrier invites. The skin around the mouth and nose is already one of the thinnest-barriered areas of the face and is exposed to saliva, toothpaste and lip products all day. When the cream is stopped, the vessels dilate again and the suppressed inflammation surfaces all at once. Reviewers describe this rebound as the usual course after stopping, and advise close follow-up during that period (Mokos 2015).
Perioral dermatitis sits within a wider pattern. A systematic review of 34 studies on topical corticosteroid withdrawal found that it was reported almost entirely on the face and genital area (99.3%), mostly in women (81.0%), mainly after long-term inappropriate use of potent steroids; burning and stinging were the commonest symptoms (65.5%) and redness the commonest sign (92.3%) (Hajar 2015). In 200 people who had applied a steroid to the face daily for at least 30 days, the reported effects included acne-like bumps, visible vessels, pigment change and perioral dermatitis, and 44.5% met criteria for a "steroid-dependent face", with redness, burning and itching whenever they stopped (Sharma 2017).
The steroid does not have to come from a tube. In 639 children using inhaled steroids for asthma, 2.9% had perioral dermatitis, and it was associated with nebulizer use, where the mist settles on the skin around the mouth (Dubus 2001).
Any steroid on the face that a physician has not prescribed for this problem. Acne spot treatments, retinoids, exfoliating acids, scrubs, facial oils and rich occlusive balms around the mouth. Fragranced lip products and heavy lip balms that spread onto the skin. Antifungal or "fungal acne" products tried without a diagnosis; a steroid can also mask a yeast or fungal infection, as the guide to fungal versus regular acne describes.
See a physician promptly if the rash spreads to the eyelids or around the eyes, appears in a child, becomes painful, crusted or blistered, looks like cold sores, or comes with swelling of the lips or face. See one too if you have used a steroid on the face for more than a few weeks and your skin burns or turns red within days of stopping, or if a flare after stopping is more than you can manage. Anyone with eczema or asthma who genuinely needs a steroid should not stop it on the strength of an article; the question is where, how strong and for how long, and that is the prescriber's call.
The link between facial steroids and perioral dermatitis is consistent across decades of clinical reports, but most studies are case series and questionnaires from dermatology clinics, many from countries where potent steroids are sold without a prescription, so they overstate how common the problem is among occasional hydrocortisone users in Canada. The withdrawal review rated its own evidence as low quality (Hajar 2015). The barrier mechanism comes from a short experiment in healthy adults plus mouse work, using a potent steroid rather than hydrocortisone (Kao 2003). The azelaic acid finding comes from ten children with no comparison group. What the sources agree on: steroids on the face should be short, supervised and deliberate, and the flare after stopping is expected, not a sign that stopping was wrong. This article is educational and is not a diagnosis or a substitute for care from a physician or dermatologist.
Literature retrieved from PubMed.
Once a physician has dealt with the steroid itself, the next problem is usually the rest of the routine: which cleanser, which moisturizer, and what to bring back first without restarting the rash. Email info@completeelixir.com with every product you use on your face and lips (toothpaste included), how long you have used each one, any steroid you have used and when you stopped, and a daylight photo. Clara will reply with which cosmetic products to pause first and what a minimal routine could look like; the medical side stays with your physician.
For more on redness around the mouth, nose and cheeks, visit the Facial Redness and Rosacea-Prone Skin Resource Centre.
Written and reviewed by Clara Song, Ph.D.
Founder and in-house formulator, COMPLETE ELIXIR
Ph.D. in Data Science · Medical Aesthetician Diploma
Last reviewed: October 4, 2026
This article distinguishes ingredient evidence, formulation rationale, finished-product evidence and professional observation. It is educational and does not replace medical diagnosis or treatment.
October 07, 2026
October 07, 2026
October 07, 2026
